AEYE Health expands Epic integration for fully autonomous, portable AI eye screening
AEYE Health announced a broader rollout of its integration with Epic, bringing point-of-care, AI-driven diabetic retinopathy (DR) screening to clinics and hospitals across the United States. With this update, care teams can order exams and receive results inside Epic in under one minute, without pulling clinicians out of their workflow. Epic users across dozens of health systems are already live.
What changes for your clinic
- Order the AI DR exam directly from the patient chart in Epic.
- A nurse or medical assistant captures one retinal image per eye using a portable camera connected to AEYE-DS.
- Results post to the record within seconds; positive findings trigger an automatic alert to ophthalmology for follow-up.
- End-to-end process takes less than a minute, requires no physician interpretation, and supports automated billing and care gap reporting.
Quality, compliance, and revenue
- Supports HEDIS measures for diabetic eye exams. See the NCQA measure specification for context: Eye Exam for Patients with Diabetes (EED).
- Fully reimbursable under CPT 92229, the first AI-specific reimbursement code in the US.
- Workflow is built to fit existing care teams and visit types, helping close gaps without adding extra clinic time.
Why it matters for care delivery
Most patients with diabetes miss their annual eye exam. Bringing DR screening into primary care, endocrinology, and diabetes centers increases screening rates, speeds referrals, and reduces avoidable vision loss.
The integration streamlines ordering, image capture, decision support, documentation, and billing into a single flow. The goal: make screening routine, fast, and accurate at the point of care.
Leadership perspective
"This enhanced integration makes diabetic retinopathy screening in Epic faster and more seamless than ever," said Zack Dvey-Aharon, Ph.D., Co-Founder & CEO of AEYE Health. "With an exam completed in under one minute and everything being automated, healthcare providers can focus on what is really important and deliver fast and accurate AI retinal screening right at the point of care. Adoption is accelerating rapidly across hospitals and clinics, bringing AEYE-DS to patients nationwide and preventing vision loss."
Implementation notes
- Set up orderables, result routing, and alerts in Epic; confirm auto-posting to the problem list and referral queues as needed.
- Train MAs and nurses on single-image capture per eye with the portable camera; validate image quality thresholds.
- Predefine pathways for positive findings: ophthalmology referral, urgency levels, and patient outreach scripts.
- Verify CPT 92229 billing automation, payer policies, and documentation prompts to reduce denials.
About AEYE Health and AEYE-DS
AEYE Health provides fully autonomous, AI-based diagnostic screening for retinal imaging with a focus on practical deployment and clinical performance. AEYE-DS is the only FDA-cleared autonomous AI for diabetic retinopathy that requires a single image per eye and is the only approved AI for a portable camera. It is currently the fastest growing solution for DR screening in the United States.
AEYE Health also supports several other major EMR platforms, extending access to AI retinal screening across diverse care settings.
Your membership also unlocks:
